tirzepatide death American Heart Association Scientific Sessions 2024 has started off with a bang! Results are in for the SUMMIT study: Treatment with (Mounjaro/ Zepbound) was associated with 38% ⬇️ in combined risk FDA approves new version of

doi: 10.1016/j.bbrc.2012.07.086 45 QueQGuoXZhanLChenSZhangZNiXet al

Reuse increases infection risk

Strict safety habits protect patients from harmful and preventable infections

Safety, Side Effects, and Precautions Known Side Effects BPC-157 TB-500 nasal spray is generally well-tolerated, but potential side effects include: Nasal-Specific Mild nasal irritation or dryness Occasional nosebleeds (rare) Temporary altered sense of smell Nasal congestion Systemic Headaches (uncommon) Dizziness (rare) Fatigue or lethargy (temporary) Localized flushing or warmth Most side effects are mild and resolve with continued use or dosage adjustment